Tags

Type your tag names separated by a space and hit enter

[LUTS in BPH patients : Comparison of silodosin versus tamsulosin, naftopidil, alfuzosin and placebo for the treatment of lower urinary tract symptoms].
Urologe A. 2019 Jul; 58(7):795-798.U

Authors+Show Affiliations

Medizinische Fakultät, Klinik für Urologie, Universitätsklinikum Freiburg, Hugstetter Str. 55, 79106, Freiburg, Deutschland.Medizinische Fakultät, Klinik für Urologie, Universitätsklinikum Freiburg, Hugstetter Str. 55, 79106, Freiburg, Deutschland. arkadiusz.miernik@uniklinik-freiburg.de.

Pub Type(s)

Comparative Study
Journal Article
Review

Language

ger

PubMed ID

31143977

Citation

Praus, F, and A Miernik. "[LUTS in BPH Patients : Comparison of Silodosin Versus Tamsulosin, Naftopidil, Alfuzosin and Placebo for the Treatment of Lower Urinary Tract Symptoms]." Der Urologe. Ausg. A, vol. 58, no. 7, 2019, pp. 795-798.
Praus F, Miernik A. [LUTS in BPH patients : Comparison of silodosin versus tamsulosin, naftopidil, alfuzosin and placebo for the treatment of lower urinary tract symptoms]. Urologe A. 2019;58(7):795-798.
Praus, F., & Miernik, A. (2019). [LUTS in BPH patients : Comparison of silodosin versus tamsulosin, naftopidil, alfuzosin and placebo for the treatment of lower urinary tract symptoms]. Der Urologe. Ausg. A, 58(7), 795-798. https://doi.org/10.1007/s00120-019-0955-9
Praus F, Miernik A. [LUTS in BPH Patients : Comparison of Silodosin Versus Tamsulosin, Naftopidil, Alfuzosin and Placebo for the Treatment of Lower Urinary Tract Symptoms]. Urologe A. 2019;58(7):795-798. PubMed PMID: 31143977.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [LUTS in BPH patients : Comparison of silodosin versus tamsulosin, naftopidil, alfuzosin and placebo for the treatment of lower urinary tract symptoms]. AU - Praus,F, AU - Miernik,A, PY - 2019/5/31/pubmed PY - 2019/7/25/medline PY - 2019/5/31/entrez SP - 795 EP - 798 JF - Der Urologe. Ausg. A JO - Urologe A VL - 58 IS - 7 SN - 1433-0563 UR - https://www.unboundmedicine.com/medline/citation/31143977/[LUTS_in_BPH_patients_:_Comparison_of_silodosin_versus_tamsulosin,_naftopidil,_alfuzosin_and_placebo_for_the_treatment_of_lower_urinary_tract_symptoms] L2 - https://dx.doi.org/10.1007/s00120-019-0955-9 DB - PRIME DP - Unbound Medicine ER -